SMTL ID : 4xdk.1 (1 other biounit)

Crystal structure of human two pore domain potassium ion channel TREK2 (K2P10.1) in complex with norfluoxetine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.60 Å

Oligo State

homo-dimer

Ligands

3 x K: POTASSIUM ION(Non-covalent)

K.1: 9 residues within 4Å: Chain A: I.108, G.109, V.217, G.218 Chain B: I.108, G.109, V.217, G.218 Ligands: K.2 4 PLIP interactions: 2 interactions with chain A, 2 interactions with chain B Metal complexes: A:G.109, A:G.218, B:G.109, B:G.218 K.2: 10 residues within 4Å: Chain A: T.107, I.108, T.216, V.217 Chain B: T.107, I.108, T.216, V.217 Ligands: K.1, K.3 5 PLIP interactions: 2 interactions with chain B, 3 interactions with chain A Metal complexes: B:T.107, B:I.108, A:I.108, A:T.216, A:V.217 K.3: 5 residues within 4Å: Chain A: T.107, T.216 Chain B: T.107, T.216 Ligands: K.2 5 PLIP interactions: 2 interactions with chain A, 3 interactions with chain B Metal complexes: A:T.107, A:T.216, B:T.107, B:T.216, B:T.216

4 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)

PC1.4: 5 residues within 4Å: Chain A: V.186, I.194, F.195, L.239, W.243 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.186, A:I.194, A:I.194, A:F.195, A:L.239, A:W.243 PC1.5: 4 residues within 4Å: Chain A: R.172, V.173, I.180, W.261 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:V.173, A:I.180, A:W.261 PC1.9: 5 residues within 4Å: Chain B: V.186, I.194, F.195, L.239, W.243 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:V.186, B:I.194, B:I.194, B:F.195, B:L.239, B:W.243 PC1.10: 2 residues within 4Å: Chain B: V.173, I.180 2 PLIP interactions: 2 interactions with chain B Hydrophobic interactions: B:V.173, B:I.180

2 x 408: (3R)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine(Non-covalent)

408.6: 11 residues within 4Å: Chain A: C.184, V.188, V.211, L.214, T.215, F.251 Chain B: A.128, I.129, I.132, P.133 Ligands: 405.7 8 PLIP interactions: 2 interactions with chain B, 6 interactions with chain A Hydrophobic interactions: B:I.132, B:P.133, A:L.214, A:T.215, A:T.215, A:F.251, A:F.251 Halogen bonds: A:C.184 408.11: 10 residues within 4Å: Chain A: I.129, I.132, P.133 Chain B: C.184, V.188, V.211, L.214, T.215, F.251 Ligands: 405.8 8 PLIP interactions: 6 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:L.214, B:T.215, B:T.215, B:F.251, B:F.251, A:I.132, A:P.133 Halogen bonds: B:C.184

2 x 405: (3S)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine(Non-covalent)

405.7: 10 residues within 4Å: Chain A: C.184, V.188, V.211, L.214, T.215, F.251, L.255 Chain B: I.129, P.133 Ligands: 408.6 7 PLIP interactions: 6 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:L.214, A:T.215, A:F.251, A:F.251, A:L.255, B:P.133 Halogen bonds: A:C.184 405.8: 11 residues within 4Å: Chain A: I.129, P.133 Chain B: C.184, V.188, V.211, L.214, T.215, L.248, F.251, L.255 Ligands: 408.11 8 PLIP interactions: 7 interactions with chain B, 1 interactions with chain A Hydrophobic interactions: B:L.214, B:T.215, B:F.251, B:F.251, B:L.255, B:L.255, A:P.133 Halogen bonds: B:C.184

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dong, Y.Y. et al., K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac. Science (2015)

Release Date

2015-03-18

Peptides

Potassium channel subfamily K member 10: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Potassium channel subfamily K member 10

Related Entries With Identical Sequence